Health Products

Dimension Vista Lipase (LIPL), Dimension Clinical Chemistry, EXL and Xpand System - Lipase Flex (LIPL) Assay (2018-09-13)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
GA9003D. Dimension EXL System - Lipase (LIPL) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
DC56
GA9003B. Dimension Clinical Chemistry System -Lipase Flex (LIPL) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
DC56
GA9003C. Dimension Xpand System - Lipase Flex (LIPL) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
DC56
18128BAA. Dimension Vista Lipase (LIPL)
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
K3056

Introduction

Affected products

A. Dimension Vista Lipase (LIPL)
B. Dimension Clinical Chemistry System -Lipase Flex (LIPL) Assay
C. Dimension Xpand System - Lipase Flex (LIPL) Assay
D. Dimension EXL System - Lipase (LIPL) Assay

Reason

Siemens Healthcare Diagnostics has confirmed lot-to-lot variability for QC and patient results when using the Dimension LIPL lots GD9002, GA9003, GB9032, GA9038 and Dimension Vista LIPL lots 18128BA, 18172BA, 18186BB. Not all laboratories will observe this issue.
The lot-to-lot bias observed for patient samples using the affected Dimension Lots when compared with a control lot could be as high as 29%. The lot-to-lot bias observed for patient samples using the affected Dimension Vista Lots when compared with a control lot ranged from 9% to 34%.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime